PTC gains after CHMP backs Translarna renewal

PTC Therapeutics Inc. (NASDAQ:PTCT) gained $5.30 (88%) to $11.30 on Friday after EMA’s CHMP recommended renewal of the conditional marketing

Read the full 202 word article

User Sign In